This document contains official instructions for Form F-11308 , Prior Authorization/Preferred Cell Adhesion Molecule (Cam) Antagonist Drugs for Rheumatoid Arthritis (Ra) and Polyarticular Juvenile Ra - a form released and collected by the Wisconsin Department of Health Services.
Q: What is Form F-11308?A: Form F-11308 is the Prior Authorization/Preferred Drug List (PA/PDL) for Cytokine and Cell Adhesion Molecule (CAM) Antagonist Drugs for Rheumatoid Arthritis (RA) and Polyarticular Juvenile RA in Wisconsin.
Q: What is the purpose of Form F-11308?A: The purpose of Form F-11308 is to request prior authorization for Cytokine and CAM Antagonist Drugs for the treatment of Rheumatoid Arthritis (RA) and Polyarticular Juvenile RA in Wisconsin.
Q: What are Cytokine and CAM Antagonist Drugs?A: Cytokine and CAM Antagonist Drugs are medications used to treat Rheumatoid Arthritis (RA) and Polyarticular Juvenile RA. They work by targeting specific molecules involved in the immune system response that contribute to inflammation and joint damage.
Q: What is Prior Authorization?A: Prior authorization is a process where healthcare providers need to seek approval from the insurance company before prescribing certain medications. It ensures that the medication is medically necessary and covered by the insurance plan.
Q: What is the Preferred Drug List (PDL)?A: The Preferred Drug List (PDL) is a list of medications preferred by the insurance plan based on their cost-effectiveness, safety, and efficacy. Drugs on the PDL may have lower co-pays or may be covered without requiring prior authorization.
Q: Who can use Form F-11308?A: Form F-11308 can be used by healthcare providers in Wisconsin who are prescribing Cytokine and CAM Antagonist Drugs for patients with Rheumatoid Arthritis (RA) or Polyarticular Juvenile RA.
Instruction Details:
Download your copy of the instructions by clicking the link below or browse hundreds of other forms in our library of forms released by the Wisconsin Department of Health Services.